Company CVAbout Fabino Enterprises Ltd 
Fabino Enterprises Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain. The Company was incorporated as "Fabino Life Sciences Private Limited" on October 27, 2011 with the Registrar of Companies, Delhi and Haryana. Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to "Fabino Life Sciences Limited". A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR 2.10 Cr
Number of Shares
21 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
10-Jan-2022
21
2.10
900000
10
Public Issue
31-Mar-2021
12
1.20
600000
10
Right Issues
01-Sep-2020
6
0.60
450000
10
Bonus Issue
08-Apr-2015
1.5
0.15
100000
10
Right Issues
03-Mar-2015
5
0.05
40000
10
Right Issues
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Aditya Mahavir Jain (52.38%)
Highest Public shareholder
Nopea Capital Services Private Limited (4.71%)
Individual Investors Holdings
28.75%
Board of Directors
Management
Designation
Remuneration
Atul Jain
CMD & Executive Director
0
Aditya Mahavir Jain
E D & Wholetime Director
0
Arihant Jain
Non Executive Director
0
Tesu Alakh
Independent Non Exe. Director
0
Gagan Gupta
Independent Non Exe. Director
0
Arihant Jain
Non Executive Director
0
Sumit Malik
Non-Exec & Non-Independent Dir
0
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Purchase
16.3566
0%
Purchase
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
1 Cr
(Quarterly Results - Jun 2021)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 5 Cr (Micro Cap)
34.00
NA
0.00%
0.36
3.22%
1.35
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
